BlackRock Group’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.41M | Buy |
1,068
+281
| +36% | +$634K | ﹤0.01% | 1630 |
|
|
2016
Q3 | $1.97M | Buy |
787
+58
| +8% | +$145K | ﹤0.01% | 1626 |
|
|
2016
Q2 | $2.23M | Buy |
729
+10
| +1% | +$30.6K | ﹤0.01% | 1488 |
|
|
2016
Q1 | $2.28M | Buy |
719
+55
| +8% | +$175K | ﹤0.01% | 1454 |
|
|
2015
Q4 | $3.41M | Sell |
664
-26
| -4% | -$134K | ﹤0.01% | 1222 |
|
|
2015
Q3 | $2.19M | Sell |
690
-35
| -5% | -$111K | ﹤0.01% | 1432 |
|
|
2015
Q2 | $2.9M | Buy |
725
+79
| +12% | +$316K | ﹤0.01% | 1359 |
|
|
2015
Q1 | $2.58M | Buy |
646
+46
| +8% | +$184K | ﹤0.01% | 1362 |
|
|
2014
Q4 | $2.94M | Sell |
600
-41
| -6% | -$201K | ﹤0.01% | 1311 |
|
|
2014
Q3 | $2.61M | Buy |
641
+16
| +3% | +$65K | ﹤0.01% | 1309 |
|
|
2014
Q2 | $2.53M | Sell |
625
-1,214
| -66% | -$4.91M | ﹤0.01% | 1340 |
|
|
2014
Q1 | $8.37M | Buy |
1,839
+421
| +30% | +$1.92M | 0.01% | 948 |
|
|
2013
Q4 | $4.97M | Sell |
1,418
-1,377
| -49% | -$4.82M | ﹤0.01% | 1072 |
|
|
2013
Q3 | $11.5M | Sell |
2,795
-42
| -1% | -$172K | 0.01% | 877 |
|
|
2013
Q2 | $11.2M | Buy |
+2,837
| New | +$11.2M | 0.01% | 828 |
|